Intravenous (IV) Compounding Automation Market Expected To Reach $3.79 Billion By 2030 As Growth Accelerates At 11.6% CAGR
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Intravenous (IV) Compounding Automation Market Size Forecast: How Large Could The Market Become By 2030?
The intravenous (IV) compounding automation market size has experienced rapid expansion in recent years. This market is projected to grow from $2.19 billion in 2025 to $2.45 billion by 2026, registering a compound annual growth rate (CAGR) of 11.9%. The increase observed in the past period can be credited to factors like the rising adoption of robotic compounding systems, the increasing demand for chemotherapy automation, a heightened focus on medication safety, the expansion of hospital and pharmacy automation, and growing awareness regarding workflow efficiency.
The intravenous (IV) compounding automation market is anticipated to experience substantial expansion over the upcoming years, with its size projected to reach $3.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. This predicted growth is driven by several factors, including greater investment in AI-powered compounding solutions, increased deployment of automated IV workstations, enhanced integration of software with hospital information systems, the spread of remote monitoring and predictive maintenance, and the ongoing creation of modular and customizable compounding platforms. Notable trends during this period are expected to feature innovations in AI and machine learning for compounding, advancements in robotic and automated equipment, the evolution of smart pump and monitoring systems, new developments in sterile compounding isolators and safety cabinets, and improvements in compact and space-saving automation technologies.
Download A Free Sample Report For Comprehensive Market Insights:
#Intravenous (IV) Compounding Automation Market Growth Drivers And Industry Catalysts
The increasing need for pharmaceutical products is anticipated to drive the expansion of the intravenous (IV) compounding automation market in the future. A pharmaceutical product refers to a substance or a mixture of substances developed for the diagnosis, treatment, prevention, or relief of diseases and health conditions in both humans and animals. IV compounding automation plays a crucial role in supporting pharmaceutical product manufacturing by facilitating the accurate, secure, and effective preparation of intricate intravenous medications. This ensures precise dosages, minimizes risks of contamination, and empowers healthcare providers to fulfill the rising need for superior quality treatments. As an illustration, in November 2023, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, showed that the total pharmaceutical production in Europe reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the escalating demand for pharmaceutical products is a primary factor fueling the growth of the intravenous (IV) compounding automation market.
Intravenous (IV) Compounding Automation Market Segment Performance And Strategic Opportunities
The intravenous (iv) compounding automation market covered in this report is segmented –
1) By Product Type: Robotic Compounding Systems, Automated Compounding Devices, Software Solutions, Other Product Types
2) By Service: Installation, Maintenance, Training, Consulting, Support, System Integration, Validation, Software Updates, Calibration, Remote Monitoring
3) By Application: Chemotherapy, Parenteral Nutrition, Antibiotics, Other Applications
4) By End-User: Hospitals, Compounding Pharmacies, Oncology Centers, Other End-Users
Subsegments:
1) By Robotic Compounding Systems: Robotic Arm Based Systems, Closed System Robotic Compounding Units, Hazardous Drug Handling Robots, Sterile Preparation Robotic Platforms
2) By Automated Compounding Devices: Volumetric Compounding Devices, Gravimetric Compounding Devices, Multi Chamber Compounding Units, Automated Parenteral Nutrition Compounding Devices
3) By Software Solutions: Compounding Workflow Management Software, Dose Verification Software, Barcode Based Medication Safety Software, Compounding Data Analytics And Reporting Software
4) By Other Product Types: Semi Automated Compounding Systems, Isolator Based Compounding Systems, Sterile Admixture Preparation Cabinets, Hybrid Compounding Assistance Devices
Intravenous (IV) Compounding Automation Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the intravenous (iv) compounding automation market are Becton Dickinson and Company, Baxter International Inc., Grifols S.A., ICU Medical Inc., Omnicell Inc., Fresenius Kabi AG, Equashield Medical Ltd., Health Robotics S.r.l., Loccioni Group, Loccioni Group, OPTIMA pharma GmbH, Medimix Systems AG, ARxIUM Inc., General Healthy Co. Ltd., PharmaScope Onco Automation B.V., Comecer SpA, Syntegon Technology GmbH, Parata Pharmacy Automation, B. Braun SE, Aesynt Incorporated, Shenzhen Broadcare Robots Co. Ltd.
Access The Complete Intravenous (IV) Compounding Automation Market Report:
Intravenous (IV) Compounding Automation Market Regional Analysis And Leading Geography
North America was the largest region in the intravenous (IV) compounding automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) compounding automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
